Navigation Links
Hope for Marburg treatment: vaccine successful in primates

The deadly Marburg virus that had affected a total of 423 cases in Angola,// which had left 357 dead, may finally have a treatment in the form of a vaccine.

A virus causes Marburg hemorrhagic fever from the same family of virus that cause Ebola hemorrhagic fever. The disease is a rare condition but have the potential of causing an outbreak very fast. The symptoms begin with severe headaches and feeling of severe unwell. Patients develop severe hemorrhagic manifestations and often turn fatal with bleedings from various locations. There is no specific treatment currently available.

In another trial a few years ago, researchers from National Institutes of Health, US, had developed a vaccine from dead virus called adenovirus. This vaccine had protected macaques from the Ebola virus.

In a new research, scientists from Public Health Agency of Canada have developed the vaccine from live deactivated virus that is said to be more effective as it is required in small doses and is easier to produce. The vaccine is med from the virus that causes the disease vesicular stomatitis in the farm animals. After genetically modifying the virus to make it harmless, inoculations of the live virus makes the human bodies to identify the protein coverings of the virus and makes them fight the virus of Ebola and Marburg. The scientists had been able to successfully test the vaccine in macaques
'"/>




Page: 1

Related medicine news :

1. New Vaccine To Combat The Deadly Marburg Virus
2. Mainstream medicine collides with alternate treatment: increasing health risks
3. New hope for cancer victims – will vaccine cure the deadly bug
4. New vaccine helps allergy and asthma patients
5. Man against HIV – new vaccine ready for human trials
6. New vaccine helps allergy and asthma patients
7. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
8. HIV did not arise from polio vaccine
9. Double impact vaccine
10. High Demand for a child vaccine
11. A new vaccine for leukemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: